Skip to main content
Screener/Healthcare/Biotechnology

DFTX — Definium Therapeutics, Inc.

NASDAQ
$42.58+6.42 (+17.74%)
Mid CapUnder $50HealthcareHigh Beta
$6.35
$39.16
$39.25
$44.53
EPS (TTM)$-2.49
P/E Ratio-10.34
Dividend Yield—
Market Cap$2.67B
Volume11.13M
Prev Close$36.18
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$77.1M$-0.71——
Q4 '25$0-$50.4M$-0.50——
Q3 '25$0-$67.3M$-0.78——
Q2 '25$0-$42.7M$-0.50——
Q1 '25$0-$23.3M$-0.35——
Q4 '24$0-$34.7M$-0.41——
Q3 '24$0-$13.7M$-0.17——
Q2 '24$0-$5.9M$-0.08——
Get Your Daily Market Recap